Citation Impact
Citing Papers
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
2003 StandoutScience
A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation
2003 StandoutNobel
Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
2005 StandoutNobel
Akt/Protein Kinase B Isoforms Are Differentially Regulated by Epidermal Growth Factor Stimulation
2000
Direct conversion of fibroblasts to functional neurons by defined factors
2010 StandoutNatureNobel
Basaloid Squamous Cell Carcinoma of the Head and Neck
2000
Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma
2004
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Bannayan‐Riley‐Ruvalcaba syndrome
1992
Glycosylation: Heterogeneity and the 3D Structure of Proteins
1997
Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis
1995
Targeting genes for self-excision in the germ line
1999 StandoutNobel
Chemoradiotherapy of Locally Advanced Esophageal Cancer
1999 Standout
Post-transcriptional gene regulation by mRNA modifications
2016 Standout
A WW domain-containing Yes-associated protein (YAP) is a novel transcriptional co-activator
1999
Classification of Surgical Complications
2004 Standout
STAM, Signal Transducing Adaptor Molecule, Is Associated with Janus Kinases and Involved in Signaling for Cell Growth and c-myc Induction
1997
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
1990 Standout
Esophageal Cancer
2003 Standout
Lessons from Hereditary Colorectal Cancer
1996 Standout
The role of the E6-p53 interaction in the molecular pathogenesis of HPV
1999
Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus
1992 Standout
The roles of enzyme localisation and complex formation in glycan assembly within the Golgi apparatus
2004 StandoutNobel
Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
2005 StandoutNobel
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
2000 Standout
The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAP
2005 Standout
Mutation analysis of EP300 in colon, breast and ovarian carcinomas
2002
TEAD mediates YAP-dependent gene induction and growth control
2008 Standout
Oesophageal carcinoma
2013 Standout
Lack of intermediate‐affinity interleukin‐2 receptor in mice leads to dependence on interleukin‐2 receptor α, β and γ chain expression for T cell growth
1996
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
2007 Standout
Chromosome engineering in mice
1995 Nature
Mutations of theAPC adenomatous polyposis coli) gene
1993
NF-κB regulation in the immune system
2002 Standout
Quality of Complication Reporting in the Surgical Literature
2002
CA 72-4 Serum Marker–A New Tool in the Management of Carcinoma Patients
1995
p63 is a p53 homologue required for limb and epidermal morphogenesis
1999 StandoutNature
Epigenetic modifications and human disease
2010 Standout
Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma
2001
MUC1 and the MUCs: A Family of Human Mucins with Impact in Cancer Biology
2004
Cancer as an evolutionary and ecological process
2006 Standout
Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines
2000 Nature
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Activity of Anti-epidermal Growth Factor Receptor Monoclonal Antibody C225 against Glioblastoma Multiforme
2002
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis
2002 StandoutNobel
Control of metastasis by Asn-linked, 1-6 branched oligosaccharides in mouse mammary cancer cells
1999
Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals
2007 Standout
Detection of RNA modifications
2010
T Cell-Specific Loss of Pten Leads to Defects in Central and Peripheral Tolerance
2001 StandoutNobel
Safety, Pharmacokinetics, and Activity of ABX-EGF, a Fully Human Anti–Epidermal Growth Factor Receptor Monoclonal Antibody in Patients With Metastatic Renal Cell Cancer
2004
Genetic progression and heterogeneity associated with the development of esophageal squamous cell carcinoma.
2001
Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells
2001 StandoutNobel
MCG10, a Novel p53 Target Gene That Encodes a KH Domain RNA-Binding Protein, Is Capable of Inducing Apoptosis and Cell Cycle Arrest in G2-M
2000
HOW CELLS RESPOND TO INTERFERONS
1998 Standout
Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1
1991 StandoutNobel
NF-κB/Rel Participation in the Lymphokine-Dependent Proliferation of T Lymphoid Cells
2001
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
2000 StandoutScience
Cancer Cell Cycles
1996 StandoutScience
Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180
1991 StandoutNobel
Pten is essential for embryonic development and tumour suppression
1998 Standout
Surgical Management of Esophageal Carcinoma
1999
Esophageal Cancer: Associated Factors with Special Reference to the Kashmir Valley
2012
Transcriptional control of human p53-regulated genes
2008 Standout
Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids
2000 StandoutNobel
Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer
2007 Standout
Homogeneous Glycopeptides and Glycoproteins for Biological Investigation
2002 StandoutNobel
Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.
1985
Increased expression of highly branched N-glycans at cell surface is correlated with the malignant phenotypes of mouse tumor cells.
1997
Viruses in Human Cancers
1991 StandoutScienceNobel
Cellular and Molecular Characterization of the scurfy Mouse Mutant
1999 StandoutNobel
Chemically tunable mucin chimeras assembled on living cells
2015 StandoutNobel
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma
1999 Standout
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
1997 StandoutScience
Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells.
1991 StandoutNobel
Global cancer statistics, 2012
2015 Standout
Chemical and Biological Strategies for Engineering Cell Surface Glycosylation
2001 StandoutNobel
c-Abl Regulates p53 Levels under Normal and Stress Conditions by Preventing Its Nuclear Export and Ubiquitination
2001 StandoutNobel
Oesophageal squamous cell carcinoma: I. A critical review of surgery
1980
Activity of Anti-epidermal Growth Factor Receptor Monoclonal Antibody C225 against Glioblastoma Multiforme
2002
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
The Interleukin-2 Receptor γ Chain: Its Role in the Multiple Cytokine Receptor Complexes and T Cell Development in XSCID
1996
Works of Shozo Mori being referenced
Characteristics of two cell lines (TE-1 and TE-2) derived from human squamous cell carcinoma of the esophagus.
1979
Basaloid-Squamous Carcinoma of the Esophagus
1996
Low Incidence of a Nucleotide Sequence Alteration of the Neurofibromatosis 2 Gene in Human Breast Cancers
1995
An immunohistochemical analysis for cancer of the esophagus using monoclonal antibodies specific for modified nucleosides
1993
Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification
1994
Altered Glycosylation of Membrane Glycoproteins Associated with Human Mammary Carcinoma
1992
Accumulation of genetic alterations during esophageal carcinogenesis
1994
The APC (adenomatous polyposis coli) gene: A novel mutation in an FAP patient and a DdeI polymorphism in the 5′ noncoding region
1993
Differences in the interleukin‐2 (IL‐2) receptor system in human and mouse: α chain is required for formation of the functional mouse IL‐2 receptor
1995
Juvenile polyposis coli
1982
Stimulation of Polyomavirus DNA Replication by Wild-Type p53 Through the DNA-Binding Site
1994
A Prospective Randomized Trial of Extended Cervical and Superior Mediastinal Lymphadenectomy for Carcinoma of the Thoracic Esophagus
1998
Follow‐up results after resection of thoracic esophageal carcinoma
1978
Frequent loss of heterozygosity in the region including BRCA1 on chromosome 17q in squamous cell carcinomas of the esophagus.
1994
Comparison of Serum Assays for TAG-72, CA19-9 and CEA in Gastrointestinal Carcinoma Patients
1989